Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.

MLA

Zehra, Kanli, et al. “Fisetin and/or Capecitabine Causes Changes in Apoptosis Pathways in Capecitabine-Resistant Colorectal Cancer Cell Lines.” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 397, no. 10, Oct. 2024, pp. 7913–26. EBSCOhost, https://doi.org/10.1007/s00210-024-03145-0.

APA

Zehra, K., Banu, A., Can, E., & Hülya, C. (2024). Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(10), 7913–7926. https://doi.org/10.1007/s00210-024-03145-0

Chicago

Zehra, Kanli, Aydin Banu, Erzik Can, and Cabadak Hülya. 2024. “Fisetin and/or Capecitabine Causes Changes in Apoptosis Pathways in Capecitabine-Resistant Colorectal Cancer Cell Lines.” Naunyn-Schmiedeberg’s Archives of Pharmacology 397 (10): 7913–26. doi:10.1007/s00210-024-03145-0.